Sort
82,697 grants matching “vaccine development”
Computational Algorithms, Methods, and Tools for Structure-Based Vaccine Design
$991,870Peter D Kwong · National Institute Of Allergy And Infectious Diseases · ZIC · FY2017 · AI
Computational Tools for Protein Crystallization and Structural Analysis
$991,870Peter D Kwong · National Institute Of Allergy And Infectious Diseases · ZIC · FY2017 · AI
Seriodiagnostic arrays for biodefense and emerging infectious diseases
$991,855David Huw Davies · Immport Therapeutics, Inc. · R44 · FY2010 · AI
Studies of Receptor Interactions and Effects of Alarmins
$991,767Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
SDMC: HIV Vaccine Trials Network
$991,756Peter B. Gilbert · Fred Hutchinson Cancer Center · UM1 · FY2025 · AI
Coronavirus Pathogenesis and Broadly Protective Vaccine Development
$991,645Matthew Memoli · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
St. Jude/Memphis IMPAACT Clinical Trials Unit (Composite)
$991,587Patricia Michele Flynn · St. Jude Children'S Research Hospital · U01 · FY2011 · AI
Point-of-care antimicrobial susceptibility testing based on simultaneous tracking of multi-phenotypic features of single bacterial cells
$991,540Shaopeng Wang · Arizona State University-Tempe Campus · R01 · FY2019 · AI
Point-of-care antimicrobial susceptibility testing based on simultaneous tracking of multi-phenotypic features of single bacterial cells
$991,540Shaopeng Wang · Arizona State University-Tempe Campus · R01 · FY2020 · AI
Safeguard the Household
$991,536Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · U19 · FY2008 · AI
A dual vaccine strategy against filovirus infection
$991,533Richard W Compans · Emory University · R01 · FY2012 · AI
PfSPZ Vaccines: Quality Systems, Manufacturing, Regulatory, and Clinical Quality and Data Management Support for Product Commercialization
$991,532Stephen Lev Hoffman · Sanaria, Inc. · SB1 · FY2016 · AI
Primate Studies
$991,499Preston A Marx · University Of Pennsylvania · P01 · FY2010 · AI
Washington Entrepreneurial Research Evaluation and Commercialization Hub
$991,450Rodney J.y. Ho · University Of Washington · U01 · FY2019 · HL
SUPPORT FOR NATIONAL PRIMATE RESEARCH CENTER
$991,407Joseph E Robertson · Oregon Health & Science University · P51 · FY2008 · RR
Establishment/Maintenance of Biomedical Research Colony
$991,259Thomas J. Rowell · University Of Louisiana At Lafayette · U42 · FY2007 · RR
i-AKC: Integrated AIRR Knowledge Commons
$991,180Lindsay G. Cowell · Ut Southwestern Medical Center · U24 · FY2025 · AI
BCG overexpressing a small molecule STING agonist as a vaccine for TB
$991,112Todd Wallach · Oncosting Llc · R44 · FY2025 · AI
Adjuvanted DNA Vaccine for Immunotherapy HIV Infection
$991,097Powderject Vaccines, Inc. · P01 · FY2001 · AI
Technologies to Advance Next Generation Anthrax Vaccines
$991,091Vidadi Yusibov · Center For Expermental Software Engr Md · N01 · FY2014 · AI
Therapeutic Antibodies for CMV
$990,935Lawrence Michael Kauvar · Trellis Bioscience, Inc. · R44 · FY2014 · AI
Therapeutic Antibodies for CMV
$990,877Lawrence Michael Kauvar · Trellis Bioscience, Inc. · R44 · FY2015 · AI
Universal Attenuated Malaria Sporozoite Vaccine and Challenge System
$990,720Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2008 · AI
Development of sG as a human vaccine against Nipah/Hendra
$990,669Timothy R Fouts · Profectus Biosciences, Inc. · R01 · FY2013 · AI
Nonclinical Development of an Improved Polio Vaccine
$990,662Gregory John Tobin · Biological Mimetics, Inc. · R44 · FY2022 · AI